Various researchers have described the suppressing role of PTX-3 in cancer through complement regulation, as PTX-3 deficiency has been linked with increased susceptibility to tumorigenesis, dysregulated inflammation and signaling pathways, angiogenesis, enhanced macrophage differentiation, and disruption in modulation of host immune responses [46,79]. The gene discussed is PTX3; the disease is cancer.